(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 2.22% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.34%.
Bruker's revenue in 2025 is $3,438,900,000.On average, 16 Wall Street analysts forecast BRKR's revenue for 2025 to be $529,970,710,272, with the lowest BRKR revenue forecast at $508,091,185,536, and the highest BRKR revenue forecast at $546,532,294,968. On average, 16 Wall Street analysts forecast BRKR's revenue for 2026 to be $536,504,179,464, with the lowest BRKR revenue forecast at $507,635,362,104, and the highest BRKR revenue forecast at $560,662,821,360.
In 2027, BRKR is forecast to generate $561,574,468,224 in revenue, with the lowest revenue forecast at $519,182,889,048 and the highest revenue forecast at $591,506,873,592.